Thomas Watkins - Apr 28, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
4
Date filed
5/2/2022, 06:15 PM
Previous filing
Jun 14, 2021
Next filing
Jun 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +4.22K +5.95% 75.2K Apr 29, 2022 By Trust F1
holding HZNP Ordinary Shares 6K Apr 28, 2022 Direct
holding HZNP Ordinary Shares 10K Apr 28, 2022 By Family Limited Partnership

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Award $0 +3.91K $0.00 3.91K Apr 28, 2022 Ordinary shares 3.91K Direct F1
transaction HZNP Restricted Stock Units Options Exercise $0 -4.22K -100% $0.00* 0 Apr 29, 2022 Ordinary shares 4.22K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.